Identification of hub genes and small-molecule compounds related to intracerebral hemorrhage with bioinformatics analysis

Abstract

BackgroundBecause of the complex mechanisms of injury, conventional surgical treatment and early blood pressure control does not significantly reduce mortality or improve patient prognosis in cases of intracerebral hemorrhage (ICH). We aimed to identify the hub genes associated with intracerebral hemorrhage, to act as therapeutic targets, and to identify potential small-molecule compounds for treating ICH.MethodsThe dataset, consisting of data from four perihematomal brain tissues and seven contralateral brain tissues, was downloaded from the Gene Expression Omnibus (GEO) database and screened for differentially expressed genes (DEGs) in ICH, with a fold change (FC) value of (|log2FC|) > 2 and a P-value of <0.05 set as cut-offs. The functional annotation of DEGs was performed using Gene Ontology (GO) resources, and the cell signaling pathway analysis of DEGs was performed using the Kyoto Encyclopedia of Genes and Genomes (KEGG), with a P-value of <0.05 set as the cut-off. We constructed a protein-protein interaction (PPI) network to clarify the interrelationships between the different DEGs and to select the hub genes with significant interactions. Next, the DEGs were analyzed using the CMap tool to identify small-molecule compounds with potential therapeutic effects. Finally, we verified the expression levels of the hub genes by RT-qPCR on the rat ICH model.ResultA total of 59 up-regulated genes and eight down-regulated genes associated with ICH were identified. The biological functions of DEGs associated with ICH are mainly involved in the inflammatory response, chemokine activity, and immune response. The KEGG analysis identified several pathways significantly associated with ICH, including but not limited to HIF-1, TNF, toll-like receptor, cytokine-cytokine receptor interaction, and chemokine molecules. A PPI network consisting of 57 nodes and 373 edges was constructed using STRING, and 10 hub genes were identified with Cytoscape software. These hub genes are closely related to secondary brain injury induced by ICH. RT-qPCR results showed that the expression of ten hub genes was significantly increased in the rat model of ICH. In addition, a CMap analysis of three small-molecule compounds revealed their therapeutic potential.ConclusionIn this study we obtained ten hub genes, such as IL6, TLR2, CXCL1, TIMP1, PLAUR, SERPINE1, SELE, CCL4, CCL20, and CD163, which play an important role in the pathology of ICH. At the same time, the ten hub genes obtained through PPI network analysis were verified in the rat model of ICH. In addition, we obtained three small molecule compounds that will have therapeutic effects on ICH, including Hecogenin, Lidocaine, and NU-1025.

Mechanism Study of the Protective Effects of Sodium Tanshinone IIA Sulfonate Against Atorvastatin-Induced Cerebral Hemorrhage in Zebrafish: Transcriptome Analysis

“…In line with these results, Liu et al showed that the HIF-1 and PI3K/Akt signaling pathways were involved in hemorrhage stroke by in-depth analysis of the gene expression profile of human cerebral hemorrhage brain samples ( Liu et al, 2019 ). Thus, HIF-1 and its regulators, including the PI3K/Akt and MAPK signaling pathways, might be involved in the protective effect of STS against Ator-induced cerebral hemorrhage in zebrafish ( Figure 6 ).…”

Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma

“…Wesierska-Gadek et al found that NU1025 can play a role in inhibiting proliferation and promoting apoptosis in breast cancer cells by destroying cellular DNA [ 53 ]. Recently, multiple studies predicted that NU1025 could be used for the treatment of intracerebral and hepatocellular carcinoma (HCC) through bioinformatics analysis [ 54 , 55 ]. Anisomycin has been reported to have anti-cancer effects in multiple cancers.…”

Histone methyltransferase and drug resistance in cancers

“…For example, PRMT1, the most active member of the PRMTs family, can catalyze methylation of the FMS-like receptor tyrosine kinase 3- internal tandem duplication protein at arginine 972/973. It can promote the proliferation of leukemia cells in acute myeloid leukaemia [ 49 – 51 ]. Other studies showed that overexpression of PRMT1 promotes metastasis and invasion of lung cancer through methylation of E-cadherin and Twist1 (a basic helix-loop-helix transcription factor) [ 52 ].…”